CLINICAL_TRIALS
research
· 2017-03-03
Clinical Trial Update: Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy [Phase 4]
Summary
This Phase 4 clinical trial evaluates converting patients from clonazepam to Onfi (clobazam) in medically refractory epilepsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Refractory Epilepsy | Phase 4 | Status: UNKNOWN